Wednesday, May 31, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

NAMRU-3 Deployed to Sudan: Yellow Fever Death Toll Hits 164

by Global Biodefense Staff
December 4, 2012

Yellow Fever VirusThe World Health Organization (WHO) yesterday announced the acute viral hemorrhagic disease yellow fever has killed at least 164 people over the last three months in Sudan’s western region of Darfur. 

The latest outbreak of the mosquito-borne virus has been concentrated in central Darfur. “Between 2 September and 29 November, the total number of suspected yellow fever cases has reached 677, including 164 deaths,” the WHO statement said. Nearly half the yellow fever cases were in people between the ages of 15 and 30, it said, and about a quarter were children aged five to 15.

Healthcare is provided almost entirely by aid agencies in parts of Darfur, where armed conflict has been raging for a decade resulting in thousands of casualties and ongoing security challenges for vaccination campaigns. 

A large-scale vaccination campaign is underway to counter the surge in yellow fever that began in September after a heavy rainy season created additional breeding sites for disease-carrying mosquitoes. According to the WHO, the campaign is over halfway towards the goal of reaching 3.6 million people in affected areas of Darfur.

In addition to the epidemiology and surveillance assistance from the WHO and other organizations, the US Naval Medical Research Unit No. 3 (NAMRU-3) has deployed a team to Sudan to support laboratory analysis of collected samples as well as conduct training sessions at the National Public Health Laboratory, according to Examiner.com. 

NAMRU-3 is based in Cairo, Egypt and conducts research and surveillance to support military personnel deployed to Africa, the Middle East, and Southwest Asia. The mission also includes regional public health capacity-building, evaluation of vaccines, therapeutic agents, diagnostic assays, and vector control measures. 

The organization operates the largest DoD overseas laboratory, with a biosafety level 3 biocontainment space and field and hospital study sites located throughout Egypt. NAMRU-3 also serves as the regional influenza reference laboratory for the Eastern Mediterranean Regional Office (EMRO) of the World Health Organization (WHO) with close ties to the influenza laboratory at the U.S. Centers for Disease Control and Prevention (CDC). 

Tags: BiosafetyMosquito-BorneYellow Fever

Related Posts

Vials of finished vaccines
Funding News

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics
Industry News

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023
Medical Countermeasures

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
Load More

Latest News

Vials of finished vaccines

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

April 26, 2023
Biodefense Headlines – 25 April 2023

Biodefense Headlines – 25 April 2023

April 25, 2023
Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2023 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2023 Stemar Media Group LLC